GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: LCB-01,0371 | LCB-01-0371 | LCB01-0371
Compound class:
Synthetic organic
Comment: Delpazolid (LCB01-0371) is an oxazolidinone antibacterial [1] that was developed for antitubercular activity.
|
|
|||||||||||||||||||||||||||||||||||
| No information available. |
Summary of Clinical Use ![]() |
| A Phase 2 trial for pulmonary tuberculosis has been completed. |
| Clinical Trials | |||||
| Clinical Trial ID | Title | Type | Source | Comment | References |
| NCT02836483 | A Phase II Clinical Study of LCB01-0371 to Evaluate the EBA, Safety and PK | Phase 2 Interventional | LegoChem Biosciences, Inc | ||